Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.53 -0.01 (-1.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) Return on Sales [ROS] (2025 - 2026)

Updated

Citius Pharmaceuticals' Return on Sales [ROS] was -785.39% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 1145.56 percentage points from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Citius Pharmaceuticals' Return on Sales [ROS] was -863.92% through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Citius Pharmaceuticals 14.55 Mn 23.85 Mn 1.00 Mn -785.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -785.39%
Mar 31, 2026 -1,930.96%
Dec 31, 2025 -228.68%
API Access

Citius Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEY